Diagnostic Equipment for Alzheimer's Disease

The diagnosis of Alzheimer's disease and the assessment of the risk of manipulation were realized using the internationally accepted MMSE and ADL scales in combination with dynamic electroencephalography (EEG). The testing process is non-invasive, touch-control interactive, one-button operation, which plays a better role in controlling, improving and managing Alzheimer's disease for early detection and prevention.

44 million people worldwide are living with Alzheimer's disease (AD) today, and the number of cases is projected to increase by about 4.6 million per year, doubling every 10 years, to more than 115 million cases worldwide by 2040.

"A lot of unnecessary tragedies can be avoided if patients and families are informed about Alzheimer's disease early on and know what to expect."

-Michelle Barclay, President of the International Alzheimer's Disease Association

September 21, 2023 is the 30th World Alzheimer's Day, with the theme "Never too early, never too late".
Alzheimer's disease is a common neurological disorder characterized by mental retardation and cognitive decline. This disease is gradually becoming one of the major diseases among the elderly population worldwide.

Etiology:The cause of Alzheimer's disease is not fully understood, but most studies have shown that the development of the disease is linked to a variety of factors, including genetic factors, abnormal protein deposits, neurotransmitter imbalances, and neuronal damage.

1. Genetic factors

2. Abnormal protein deposition

3. Neurotransmitter imbalance

4. Neuronal damage

Symptoms:Scholars have found that people with Alzheimer's disease produce abnormal proteins such as beta-amyloid (Aβ), tau proteins, and other proteins that clump together to form plaques and neurofibrillary tangles in the nerve cells of the brain, which may be the main cause of neuronal death and cognitive decline.

1.Memory impairment

2.Behavioral and language disorders

3.Spatial sense disorder

4.Cognitive impairment

5.disorientation disorder

6. Sleep disorders

1.Rapid diagnosis

2.Immediate diagnostic data

3. Non-invasive testing process

4. Sharp and reliable measurement value

● Founded in 2011,is a biomedical field of medical equipment research and development, production and sales as one of the high-tech enterprises

● The company has more than 50 R&D professionals with PhDs and Masters in the field of biomedical science.

● Rely on the core technologies- the bioelectricity technology, the pulsed magnetic control technology and the electroencephalogram-driven control technology;

● Establishment of Hebei Functional Medical Testing Engineering and Technology Research Center, Electromagnetic Interference and Electrostatic Protection Academician Workstation, Postdoctoral Innovation and Practice Base

● R&D center passed the U.S. CMMI certification; awarded the title of "Giant Plan" innovation and entrepreneurship team by the People's Government of Hebei Province.

HSAP products are used in 32 provinces, municipalities and autonomous regions in China, and are exported to Germany, France, Korea, Turkey, the United Arab Emirates and other countries.

Hot Tags: diagnostic equipment for alzheimer's disease, China diagnostic equipment for alzheimer's disease manufacturers, suppliers, factory, memory training program, brain function training app, brain training service, mental workout app, cognitive training app, mental exercise aid